13-06-2026 07:52 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company Background
Concord Biotech Ltd.
 
Industry : Pharmaceuticals & Drugs House : Private
BSE Code 543960
ISIN Demat INE338H01029
Book Value 193.06
NSE Code CONCORDBIO
Dividend Yield % 0.56
Market Cap 141634.65
P/E 53.80
EPS 25.17
Face Value 1  
 
Incorporation Year 1984  
Registered Office 1482-1486 ,Trasad Road,Dholka, Ahmedabad Dist,
Gujarat-382225 .
ISINNO INE338H01029  
Phone 02714-222604 / 398200  
E-mail complianceofficer@concordbiotech.com
URL www.concordbiotech.com
Industry Pharmaceuticals & Drugs  
Chairman Sudhir Vaid  
Managing Director Sudhir Vaid  
Company Secretary Paritosh Trivedi  
Listing BSE,NSE  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.